Lowenstein Sandler LLP holds 7.2% of Cyabra (NASDAQ: CYAB)
Rhea-AI Filing Summary
Cyabra, Inc. ownership disclosure: Lowenstein Sandler LLP reported beneficial ownership of 1,000,000 shares of Cyabra common stock as of March 27, 2026. The filing states this equals approximately 7.2% of the 13,814,167 shares outstanding reported to the reporting person on that date.
The reporting person reports sole voting and sole dispositive power over the 1,000,000 shares. The Schedule 13G is signed by David Wissert as General Counsel on April 1, 2026.
Positive
- None.
Negative
- None.
Insights
Lowenstein Sandler LLP holds a material minority stake (7.2%) in Cyabra.
The filing shows 1,000,000 shares beneficially owned and reports sole voting and dispositive power. Ownership is calculated from 13,814,167 shares outstanding as of March 27, 2026, per the disclosure.
Significant items to watch in future filings include any increase or sale of this stake and whether ownership crosses regulatory thresholds that would change filing status. Timing of such changes would appear in subsequent ownership reports.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
Sole dispositive power regulatory
FAQ
What stake does Lowenstein Sandler LLP report in Cyabra (CYAB)?
What date is used to calculate the ownership percentage in the Schedule 13G for CYAB?
Who signed the Schedule 13G reporting Lowenstein Sandler's stake in CYAB?
AI-generated analysis. How Rhea-AI works. Not financial advice.